Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NanaBis for metastatic bone pain
NCT04808531Phase 3Unknown
- Sponsor
- Medlab Clinical
- Start
- Nov 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of NanaBis in bone metastases, sponsored by Medlab Clinical. Status: unknown.
02
Drugs
NanaBis
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT04808531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04808531.